Health impairment caused by coumarin?
Schwietzer, C.H.
Deutsche Medizinische Wochenschrift 97(41): 1573
1972
ISSN/ISBN: 0012-0472 PMID: 5075801 Document Number: 48829
Document emailed within 1 workday
Related Documents
Ciorciaro, C.; Hartmann, K.; Stoller, R.; Kuhn, M. 1996: Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring) Schweizerische Medizinische Wochenschrift 126(49): 2109-2113Kyvik, K.R.; Moen, B. 1990: Nervous system impairment caused by solvents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(11): 1342-1345
Haralampiev, K.; Kitanoski, B. 1980: Hearing impairment caused by a landmine explosion and the possibilities of its prevention and therapy Vojnosanitetski Pregled 37(3): 169-171
Ishiko, S.; Ogasawara, H.; Yoshida, A.; Hanada, K. 1998: The use of scanning laser ophthalmoscope microperimetry to detect visual impairment caused by macular photocoagulation Ophthalmic Surgery and Lasers 29(2): 95-98
Li, W.P.; Wang, F.F.; Lu, J.M.; Wu, S.C.; Wu, W.B.; Liu, R.Y.; Zhang, X.; Li, M.; Zhao, H.; Zhu, B.; Xu, Y.; Zhang, B. 2017: Change of white matter neuronal integrity associated with spatial navigation impairment in mild cognitive impairment Zhonghua Yi Xue Za Zhi 97(3): 182-186
Konietzko, H. 1977: Impairment of health by organic solvents Die Medizinische Welt 28(46): 1870-1871
Goldman, L.S. 1998: Physician impairment and health: a brief overview Journal of the Kentucky Medical Association 96(1): 25-26
Iastrebov, V.E.; Shcherbinskiĭ, V.V. 1989: Causes of impairment in the general health status of pilots in flight (2) Voenno-Meditsinskii Zhurnal 10: 43-45
Brown, M.E.; Trinkoff, A.M.; Christen, A.G.; Dole, E.J. 2002: Impairment issues for health care professionals: review and recommendations Substance Abuse 23(3 Suppl): 155-165
Brown, M.E.; Trinkoff, A.M.; Christen, A.G.; Dole, E.J. 2002: Impairment issues for health care professionals: review and recommendations Substance Abuse 23(3 Suppl): 155-165
Brown, M.E.; Trinkoff, A.M.; Christen, A.G.; Dole, E.J. 2002: Impairment issues for health care professionals: review and recommendations Substance Abuse 23(3 Suppl): 155-165
Gong, Y.; Xiong, K.-p.; Mao, C.-j.; Huang, J.-y.; Hu, W.-d.; Han, F.; Chen, R.; Liu, C.-f. 2013: Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep Zhonghua Yi Xue Za Zhi 93(33): 2637-2641
Pollard, B.; Johnston, M.; Dieppe, P. 2006: What do osteoarthritis health outcome instruments measure? Impairment, activity limitation, or participation restriction? Journal of Rheumatology 33(4): 757-763
Lyketsos, C.G.; Lopez, O.; Jones, B.; Fitzpatrick, A.L.; Breitner, J.; DeKosky, S. 2002: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study JAMA 288(12): 1475-1483
Klingemann, H.G.; Egbring, R. 1982: Coumarin necrosis Die Medizinische Welt 33(18): 676-677
Rodríguez Cuartero, A.; González Martínez, F. 1999: Coumarin resistance Anales de Medicina Interna 16(2): 103-104
Marshall, M. 1983: Various and complex effects of coumarin Münchener Medizinische Wochenschrift 125(42): 919-920
Leickert, K.H. 1982: Coumarin derivatives in the prevention of reinfarction Die Medizinische Welt 33(50): 1832-1833
Trefanec, J.; Lunda, P.; Fiserová, J.; Pitrák, V.; Kulhánková, J. 1987: Dermal coumarin necrosis due to Pelentan Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 66(5): 369-372
Brooks, L.W.; Blais, F.X. 1991: Coumarin-induced skin necrosis Journal of the American Osteopathic Association 91(6): 601-605